AIP
CMPX icon

Ameritas Investment Partners’s Compass Therapeutics CMPX Stock Holding History

Ameritas Investment Partners’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Hold
10,621
– – ﹤0.01% 2681
2026
Q1 		$56.2K Hold
10,621
– – ﹤0.01% 2032
2025
Q4 		$57K Buy
10,621
+3,085
+41% +$14.2K ﹤0.01% 2032
2025
Q3 		$26.4K Hold
7,536
– – ﹤0.01% 2541
2025
Q2 		$19.6K Hold
7,536
– – ﹤0.01% 2667
2025
Q1 		$14.3K Hold
7,536
– – ﹤0.01% 2683
2024
Q4 		$10.9K Hold
7,536
– – ﹤0.01% 2879
2024
Q3 		$13.9K Hold
7,536
– – ﹤0.01% 2816
2024
Q2 		$7.54K Hold
7,536
– – ﹤0.01% 2991
2024
Q1 		$14.9K Hold
7,536
– – ﹤0.01% 2677
2023
Q4 		$11.8K Hold
7,536
– – ﹤0.01% 2792
2023
Q3 		$14.8K Hold
7,536
– – ﹤0.01% 2664
2023
Q2 		$24K Buy
+7,536
New +$23.7K ﹤0.01% 2471

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ameritas Investment Partners's CMPX Position: Q2 2026 in Review

Ameritas Investment Partners held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 10,621 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Ameritas Investment Partners first reported a position in CMPX in Q2 2023 and has held it in 13 quarters since. The position peaked at $57K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Ameritas Investment Partners held 10,621 shares of Compass Therapeutics worth $23.3K as of Q2 2026.
  • Ameritas Investment Partners left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2681 holding.
  • Ameritas Investment Partners first reported a position in Compass Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Ameritas Investment Partners's Compass Therapeutics position peaked at $57K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.